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Abstract: Since the 1950s, several studies have been carried out to investigate the   occurrence of 
schizophrenia-like psychoses in epilepsy. The psychopathological profile comprises symptoms 
from the affective, schizophrenic, and cognitive domains and the prevalence varies between 2% 
to 20%. Classification of such conditions is performed according to their temporal relationship 
with the seizure itself. Although it is well known that epilepsy may be associated with psychotic 
disorders, it is less widely recognized that relapsing psychotic phenomena may be the first and 
only symptom of epilepsy. In this research, two patients are described who were initially referred 
for recurrent episodes of bipolar affective disorder and schizophrenic psychosis, respectively. In 
both patients, a diagnosis of relapsing postictal psychotic states due to previously undiagnosed 
epilepsy was made and consequently, treatment with antiepileptics was started. During follow 
up over several months, they remained free of both epileptic and psychotic symptoms. Given 
the kaleidoscopic nature of the postictal psychosis and full recovery from this, such psychoses 
best meet the criteria for a cycloid psychosis. These observations illustrate diagnostic and thera-
peutic pitfalls due to the conceptual disintegration emerging from the inadequate separation 
between psychiatry and neurology. Therefore, the importance of a neuropsychiatric viewpoint 
should be promoted.
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By the middle of the 19th century, neuropsychiatrists from France and Germany, 
notably Morel and Magnan, and Griesinger and Kraepelin, respectively, had identified 
a recurrent association between epilepsy and psychosis. Based on the clinical affilia-
tion, these psychoses were viewed either as an epileptic phenomenon or as part of the 
schizophrenic spectrum. Until the 1950s, the neurological vantage point dominated,1 
but following this time psychiatric aspects of epilepsy were rediscovered, resulting in 
an increase in the number of studies on schizophrenia-like psychosis in patients with 
epilepsy.2,3 Psychoses in epilepsy, that may occur either peri- or interictally, are mainly 
characterized by symptoms from the affective, schizophrenic, and cognitive domains 
such as mood instability, anxiety, hallucinations and delusions, and confusion.4–7 The 
prevalence varies from 2% to 7% but in temporal lobe epilepsy a percentage of nearly 
20% is reported.8,9 Furthermore, the incidence is higher in patients with a psychiatric 
history or longstanding epileptic manifestations.10–12 The main differential diagnosis 
is a nonconvulsive or partial complex status epilepticus.13,14
Although the Subcommission on Classification of the Commission on   
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(ILAE; http://www.ilae-epilepsy.org) has proposed a 
  classification of neuropsychiatric disorders in epilepsy, an 
internationally accepted consensus on the classification 
of psychotic syndromes associated with epilepsy is still 
lacking.15,16 Therefore, these conditions are generally clas-
sified according to their temporal relationship to the seizure 
itself, ie, ictal, postictal, and interictal psychosis.16,17 Ictal 
psychosis is commonly associated with a partial complex sta-
tus, lasts for hours to days, and is characterized by impaired 
consciousness. Interictal psychosis is not directly related to 
the ictus, can be either brief or chronic, and its characteristics 
are auditory hallucinations, paranoid delusions, and affective 
symptoms, or a purely delusional state. Chronic forms closely 
resemble schizophrenia. The most common form is the pos-
tictal psychosis that may persist for days or weeks. Mostly, 
a characteristic lucid interval is present that can last from 1 
to 6 days between the epileptic seizure and the onset of psy-
chosis. The psychotic symptoms are pleomorphic (delusions, 
hallucinations, catatonia) and frequently include confusion. 
Affective symptoms are often prominent and bizarre and 
disorganized behaviors occur regularly. The episodes resolve 
spontaneously but often recur, generally with a similar clini-
cal picture.8,13,17 In some patients, suppression of seizures may 
provoke psychotic symptoms and/or uninhibited behaviors. 
This condition was originally described by Landolt in 1953 
who introduced the term alternative psychosis, later described 
as forced normalization, and that implies a tradeoff between 
seizure control and psychotic symptom occurrence.5,7,16
In this report, two female patients are described who were 
referred for evaluation for recurrent manic and schizophrenia-
like symptoms, respectively, that were diagnosed as postictal 
psychotic states.
Clinical observations and results
Patient A is a 41-year-old female who was admitted for the 
first time to the department of neuropsychiatry three years 
before because of disorganized behavior with motor agitation 
and euphoric mood that was preceded by a short period with 
psychiatric symptoms, especially paranoid ideation, ideas 
of reference, mood instability, inactivity, and self neglect. 
Psychiatric examination at admission showed a pleomorphic 
psychopathological picture characterized by anxiety, perplex-
ity, impaired attention and distractibility, elation, instability 
of mood, flight of ideas, associative and incoherent thinking, 
psychomotor agitation, odd and chaotic behaviors sugges-
tive of auditory hallucinatory experiences, and paranoid 
ideation. She was disorientated in time and place, had no 
insight, and experienced severe sleep disturbances. Psychi-
atric, neurological, or somatic antecedents were not present, 
nor was there a family history of neuropsychiatric disorders. 
A provisional diagnosis of subacute confusional state was 
made (ICD-10: F05.8). Extensive neurological, somatic, and 
laboratory examination, including analysis of cerebrospinal 
fluid and magnetic resonance imaging (MRI) of the brain, 
revealed no abnormalities. The patient was treated with a low 
dose of haloperidol (3 mg daily) and lorazepam (4 mg daily) 
after which the psychiatric symptoms gradually disappeared. 
Three months later she was discharged, at which time treat-
ment comprised 3 mg haloperidol per day only.
During follow up over a period of one year, she developed 
symptoms of major depression with loss of interest, inactiv-
ity, anhedonia, suicidal ideation, flattening of affect, and 
depressed mood. Neuropsychological assessment revealed 
a total IQ of 86 with a harmonic profile and motivational 
problems. Haloperidol was discontinued and the patient was 
treated with imipramine under control of the plasma concen-
tration. Lithium was later added as an additional treatment.
Because of persistent apathetic behavior, she was read-
mitted and all psychotropic drugs were discontinued. Subse-
quently, she developed psychotic symptoms, similar to those 
during the first admission and a provisional diagnosis of 
bipolar affective disorder was made. The patient was treated 
with a low dose of haloperidol, lithium, and valproic acid. 
She then collapsed twice resulting in severe facial lacerations. 
The collapses were followed by a short period of confusion, 
bizarre behavior, and perplexity. A complete reevaluation of 
her medical history was made from which it appeared that 
there had been two syncopes at the age of 19 years and, most 
probably, an astatic seizure prior to her first hospitalization. 
The collapses in her recent history were reconsidered as 
tonic-clonic seizures, which was corroborated by a 24-hour 
electroencephalography (EEG) recording showing bilateral 
frontotemporal sharp wave activity (left more pronounced 
than right). Subsequent EEG recording during sleep disclosed 
mid frontopolar epileptic activity. A definite diagnosis of 
cycloid psychosis (ICD-10: F23.0) related to epilepsy, more 
specifically postictal psychosis, was made. An MRI of the 
brain (1½ Tesla) demonstrated that, apart from a slightly, but 
discrete, dilated left temporal horn, there were no abnormali-
ties present. Psychotropics were tapered off but valproic acid 
was continued. In the following months, periods of unstable 
mood and distractibility remained without clinical signs 
of epilepsy. Carbamazepine was therefore added, however, 
its use was discontinued due to an allergic skin reaction, at 
which point it was replaced by oxcarbazepine. During fol-
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valproic acid in combination with 300 mg of oxcarbazepine 
(plasma concentrations 75 mg/L and 4.4 mg/L, respectively). 
There was no further occurrence of epileptic or psychotic 
phenomena, or disturbances in mood stability.
Patient B is a 16-year-old female who was referred for 
reevaluation of short lasting (3 days to 2 weeks) recurrent 
psychoses with full recovery since her menarche at the age 
of 13. The psychotic episodes were characterized by mood 
instability, suicidal ideation, pananxiety, confusion, auditory 
hallucinations, derealization, feelings of pathological guilt, 
and obsessive preoccupations with death. Different diagnoses 
were made elsewhere, including postmenstrual psychosis, 
attention deficit disorder, bipolar affective psychosis, cycloid 
psychosis, and schizophrenia, for which she had been treated 
with several atypical antipsychotics that had resulted in a 
weight gain of more than 20 kg. At the age of 14 years, 
using the revised Wechsler Intelligence Scale for Children 
(WISC-R), a total IQ of 71 was established. Apart from 
an euthyreotic struma, extensive somatic and neurological 
examination, including EEG and MRI of the brain, had not 
shown any abnormalities. At age 16, she was hospitalized to 
establish a definite diagnosis.
The patient is the second child of nonconsanguineous 
parents. Her mother has been treated with antiepileptics since 
her adolescence because of localization related epilepsy. The 
older sister of the patient has been diagnosed with idiopathic 
primary generalized epilepsy for which she is also treated 
with carbamazepine. In the 37th week of the pregnancy, 
the mother developed severe seizures despite maintenance 
therapy with carbamazepine. The delivery was uncomplicated 
and the patient’s birth weight was 2800 g. Her developmental 
trajectory showed delayed milestones with walking from the 
age of 14 months and first speech of monosyllabic words at 
2 years. Over the years, motor functioning remained clumsy. 
During her elementary school period, she followed a logo-
pedic and motor training program. From the age of 10 years 
until menarche, there had been one short period during which 
the patient experienced weakness of the legs. During the 2 
years prior to admission, there had been approximately 20 
brief psychotic episodes.
At admission, all psychotropics (most recently olanzap-
ine) had already been discontinued for some weeks during 
which time her body weight gradually normalized. Neurop-
sychiatric examination revealed no psychiatric symptoms. 
There were no facial dysmorphisms. Somatic or neurological 
dysfunctions were not found and laboratory tests were all 
normal. An MRI of the brain (3-Tesla) revealed no structural 
abnormalities. Neuropsychological assessment showed a total 
IQ of 88 (Weschler Adult Intelligence Scale–III [WAIS III]), 
increased   distractibility,   problems with inhibition, task 
switching, and planning, as well as reduced stress tolerance. 
An extensive clinical genetic work-up, including microarray 
analysis, revealed a small deletion at 16q23.3 that was not 
clinically relevant. A fetal anticonvulsant syndrome was ruled 
out (Department of Human Genetics, University Medical 
Centre, St. Radboud, Nijmegen).
During the hospitalization period, the patient experienced 
several short periods of psychotic symptoms, particularly 
auditory hallucinations, mood swings, affective instability, 
derealization, disorientation, thought disorder, anxieties, 
confusion, and paranoid and suicidal ideation. Although EEG 
recording after sleep deprivation during an interval without 
psychotic symptoms showed only one left frontal spike, a 
tentative diagnosis of extratemporal localization related epi-
lepsy was made and the short lasting period with weakness of 
the legs during prepuberty, was considered retrospectively as 
an astatic seizure. Subsequently, the patient was treated with 
carbamazepine in a daily dose of 500 mg (plasma concentra-
tion 6.4 mg/L). Thereafter, pleomorphic psychotic episodes 
did not recur. A definite psychiatric diagnosis of postictal 
psychosis was made and the patient was discharged. Six 
months later she was hospitalized in a specialized epilepsy 
centre for a period of 3 months because of short periods of 
altered consciousness, affective instability, weakness of the 
legs, and fine muscle twitches in both arms and legs. The daily 
dose of carbamazepine was increased to 600 mg. A 24-hour 
EEG recording demonstrated, apart from the earlier identified 
left frontal spike, a sharp K-complex. During the complete 
hospitalization period, psychotic episodes did not occur and 
no etiological factors could be established. Treatment with 
carbamazepine was continued unchanged. During follow up 
over a period of 1.5 years, she remained free of psychotic 
symptoms and, apart from one short astatic seizure, epileptic 
phenomena no longer occurred.
Discussion
Patient A, who presented at first admission with an acute 
confusional state, was initially diagnosed as suffering from 
bipolar affective disorder. Later, seizures provoked by 
changes in psychotropic medications occurred and these 
were followed by short periods of confusion and bizarre 
behavior. In patient B, a diagnosis of schizophrenia was 
made elsewhere. During a relatively long medication free 
clinical observation period, she developed relapsing brief 
psychotic episodes. Both patients made a full recovery 
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(A and B) and family load (B only), an epileptic origin was 
suspected. Although EEG recordings demonstrated only 
minimal epileptic activity in both patients, a tentative diag-
nosis of epilepsy was made and treatment with antiepileptics 
was started. Thereafter, they remained free of epileptic and 
psychotic symptoms.
Since in patient A seizures had most probably occurred 
already in late adolescence, during which she had never used 
psychotropics, psychopharmacologically induced kindling 
leading to psychotic states could be ruled out.17,18 Neither of 
the patients had previously been treated with antiepileptics, 
for which reason the phenomenon of a forced normalization 
associated psychosis can be excluded. In addition, neither 
the EEG recordings nor the clinical presentations in patients 
A and B met the criteria as proposed for this condition.17 
A limbic psychotic trigger reaction (LPTR), as hypoth-
esized by Pontius et al is also very unlikely because both 
patients showed disorientation during the act and amnesia 
for the act, in the absence of the typical out of character, 
bizarre, unplanned involuntary behaviors that are associated 
with LPTR.19,20
Because the ictus-related relapsing psychotic states 
with full recovery had a kaleidoscopic clinical picture, in 
both patients a definite diagnosis of postictal psychosis was 
justified. Interestingly, in both of the patients, sleep distur-
bances were the initial presenting symptom of the postictal 
psychosis. This phenomenon has been established via several 
observations and is recognized as a typical prodrome.21–23 No 
specific risk factors were present in either patient, although in 
patient B a family history with epilepsy, but not psychiatric 
diseases, was present.
The phenomenology of the postictal psychosis, that com-
prises affective, schizophrenic, and confusional elements, 
may be referred to as a schizophrenia-like psychosis, but 
its atypical and highly variable psychopathological picture 
fits best with the criteria for a cycloid psychosis. These 
include, apart from a subacute onset, symptoms like con-
fusion expressed as perplexity, hallucinatory experiences, 
mood swings, paranoid ideation, and pervasive experience 
of anxiety.24–27
With respect to the treatment of a postictal psychosis, 
optimal seizure control is the primary target, whereas in the 
acute phase a low dose of an antipsychotic for a restricted time 
frame may be applicable.5,28 Treatment of epilepsy with con-
comitant psychotic symptoms may, however, be complicated 
since antipsychotics have the propensity to induce seizures 
and because several anticonvulsants, especially topiramate, 
levetiracetam, and vigabatrin, may precipitate psychosis.29–31
The diagnostic fogginess as demonstrated in the patients 
reported in this study is exemplary of the major caesura that 
history has drawn between neurology and psychiatry.32 As 
a consequence, both the clinical diagnostic awareness of 
psychiatric manifestations of neurological diseases as well 
as the process of pharmacological treatment is endangered 
in patients presenting with (relapsing) atypical psychiatric 
symptoms.33 Therefore, as advocated by several authors 
over the past decade, it is important to reintegrate neurop-
sychiatry into mainstream psychiatry in an attempt to close 
the divide between psychiatry and neurology.34–36
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